PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs

Cancer statistics, 2015

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Dmitri B. Kirpotin, Daryl C. Drummond, Yi Shao et al. · Cancer Research · 2006 · 1.1K citations · Full text

Nanoparticles, Does Increase Internalization, Increase Tumor Localization +17

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

Michael M. Schmidt, K. Dane Wittrup · Molecular Cancer Therapeutics · 2009 · 559 citations · Full text

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

He Liu, P. Moy, Sae Kim et al. · PubMed · 1997 · 531 citations

Extracellular Domain, Immunology, Pathology +16

Phase I Trial of ¹⁷⁷Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Neil H. Bander, Matthew I. Milowsky, David M. Nanus et al. · Journal of Clinical Oncology · 2005 · 504 citations